Orion Oyj (OTCMKTS:ORINF) Short Interest Update

Orion Oyj (OTCMKTS:ORINF) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 371,600 shares, a decrease of 20.5% from the May 31st total of 467,700 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Orion Oyj Stock Performance

Shares of OTCMKTS ORINF opened at $47.16 on Friday. The stock’s 50-day simple moving average is $47.16 and its two-hundred day simple moving average is $45.15. Orion Oyj has a twelve month low of $47.16 and a twelve month high of $47.16.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.